Find therapies in clinical trials near you – page 52

Study of rimegepant for preventing chronic migraine in adolescents aged 12 to 17 years

Study of rimegepant for preventing chronic migraine in adolescents aged 12 to 17 years

Study of Tozorakimab to reduce exacerbations in former smokers with chronic obstructive pulmonary disease (COPD)

Study of Tozorakimab to reduce exacerbations in former smokers with chronic obstructive pulmonary disease (COPD)

Study of LY3457263 compared to placebo in adults with type 2 diabetes who are taking semaglutide or tirzepatide but have not reached their blood sugar goals

Study of LY3457263 compared to placebo in adults with type 2 diabetes who are taking semaglutide or tirzepatide but have not reached their blood sugar goals

Study comparing RO7795081 and semaglutide with placebo in adults with type 2 diabetes mellitus

Study comparing RO7795081 and semaglutide with placebo in adults with type 2 diabetes mellitus

Study of orforglipron in people with high blood pressure who are overweight or have obesity

Study of orforglipron in people with high blood pressure who are overweight or have obesity

Study of Monthly Atacicept Injections in Patients with IgA Nephropathy (Berger Disease)

Study of ALXN2420 with somatostatin analogs for adults with acromegaly to evaluate effectiveness in lowering IGF-1 levels

Study of ALXN2420 with somatostatin analogs for adults with acromegaly to evaluate effectiveness in lowering IGF-1 levels

Comparing bemnifosbuvir-ruzasvir and sofosbuvir-velpatasvir for treatment of chronic hepatitis C virus infection in adult patients

Comparing bemnifosbuvir-ruzasvir and sofosbuvir-velpatasvir for treatment of chronic hepatitis C virus infection in adult patients

Study of ruxolitinib cream applied to the skin for people with hidradenitis suppurativa

Study of ruxolitinib cream applied to the skin for people with hidradenitis suppurativa

Study of ruxolitinib cream for treating hidradenitis suppurativa in adult patients

Study of ruxolitinib cream for treating hidradenitis suppurativa in adult patients

Comparison of Risankizumab and Vedolizumab for Treatment of Moderate to Severe Ulcerative Colitis in Adults Who Have Not Received Targeted Therapies

Comparison of Risankizumab and Vedolizumab for Treatment of Moderate to Severe Ulcerative Colitis in Adults Who Have Not Received Targeted Therapies

Study of Bimekizumab for Children and Adolescents with Moderate to Severe Hidradenitis Suppurativa

Study of Bimekizumab for Children and Adolescents with Moderate to Severe Hidradenitis Suppurativa